Moderate-to-severe alopecia areata (AA) is associated with negative impacts on quality of life and health outcomes in all age groups. However, the impact on children living with this disease and their families is uniquely severe. Children and their families face the daily burden of a chronic … [Read more...] about Series: Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children
Series
Series: Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children
Moderate-to-severe atopic dermatitis is associated with negative impacts on quality of life and health outcomes in all age groups, with the impact on children and families being uniquely severe. However, the rapid pace of drug development and uncertainty around novel medications may impact the … [Read more...] about Series: Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children
Series: How Patients Fuel Innovation
Both webinars in this miniseries are now available! Watch and listen as Suz Schrandt, JD discusses the important role patients play in capturing meaningful data and how PeDRA investigators can engage them as strategy partners in data collection. Part One: Patients as Data Partners Part Two: … [Read more...] about Series: How Patients Fuel Innovation
